OBJECTIVE: To determine the association between organ dysfunction and hyperglycemia in critically ill children receiving intravenous insulin. DESIGN: Retrospective chart review (cohort study). SETTING: Pediatric intensive care unit in a university hospital. PATIENTS: n = 110 patients; inclusion criteria: ICU hospitalization from May 2005 to May 2006; insulin drip to manage hyperglycemia. EXCLUSION CRITERIA: insulin drip <48 h; diabetic patients. MEASUREMENTS: Duration of hyperglycemia: sum of hours of hyperglycemia (> or =126 mg/dl). Hypoglycemia (blood glucose <40 mg/dl). Organ dysfunction was determined per International Pediatric Sepsis Consensus Conference criteria. Multiple logistic regression models determined the association between > or =3 compared to <3 organ dysfunctions and hyperglycemia, hypoglycemia, and mortality, after adjustment for confounding variables (age, gender, PRISM score, vasopressors, steroids). MAIN RESULTS: Organ dysfunction > or =3 compared to <3 after adjustment for confounders was associated with intermittent hyperglycemia of > or =24 h (OR 6.1, CI 1.8-21.2; p = 0.004). Hyperglycemia trended towards significance with mortality [3.2 (CI 0.9-11.6, p = 0.079)]. Hypoglycemia, after adjusting for the above, was not associated with mortality. CONCLUSIONS: Organ dysfunction (> or =3 versus <3) was significantly associated with hyperglycemia for > or =24 h and hypoglycemia. Hyperglycemia trended toward significance with mortality in critically ill children. There was no association between hypoglycemia and mortality.
OBJECTIVE: To determine the association between organ dysfunction and hyperglycemia in critically ill children receiving intravenous insulin. DESIGN: Retrospective chart review (cohort study). SETTING: Pediatric intensive care unit in a university hospital. PATIENTS: n = 110 patients; inclusion criteria: ICU hospitalization from May 2005 to May 2006; insulin drip to manage hyperglycemia. EXCLUSION CRITERIA: insulin drip <48 h; diabeticpatients. MEASUREMENTS: Duration of hyperglycemia: sum of hours of hyperglycemia (> or =126 mg/dl). Hypoglycemia (blood glucose <40 mg/dl). Organ dysfunction was determined per International Pediatric Sepsis Consensus Conference criteria. Multiple logistic regression models determined the association between > or =3 compared to <3 organ dysfunctions and hyperglycemia, hypoglycemia, and mortality, after adjustment for confounding variables (age, gender, PRISM score, vasopressors, steroids). MAIN RESULTS:Organ dysfunction > or =3 compared to <3 after adjustment for confounders was associated with intermittent hyperglycemia of > or =24 h (OR 6.1, CI 1.8-21.2; p = 0.004). Hyperglycemia trended towards significance with mortality [3.2 (CI 0.9-11.6, p = 0.079)]. Hypoglycemia, after adjusting for the above, was not associated with mortality. CONCLUSIONS:Organ dysfunction (> or =3 versus <3) was significantly associated with hyperglycemia for > or =24 h and hypoglycemia. Hyperglycemia trended toward significance with mortality in critically ill children. There was no association between hypoglycemia and mortality.
Authors: Jack J M Ligtenberg; Sofie Meijering; Ymkje Stienstra; Iwan C C van der Horst; Mathijs Vogelzang; Maarten W N Nijsten; Jaap E Tulleken; Jan G Zijlstra Journal: Intensive Care Med Date: 2006-02-14 Impact factor: 17.440
Authors: Ana Lilia Ponce-Ponce De León; Gustavo Romero-Gutiérrez; Carlos Aldana Valenzuela; Francisco Ernesto González-Bravo Journal: Pediatr Int Date: 2005-02 Impact factor: 1.524
Authors: A Chiaretti; R De Benedictis; A Langer; C Di Rocco; C Bizzarri; A Iannelli; G Polidori Journal: Childs Nerv Syst Date: 1998-09 Impact factor: 1.475
Authors: Vijay Srinivasan; Philip C Spinella; Henry R Drott; Carey L Roth; Mark A Helfaer; Vinay Nadkarni Journal: Pediatr Crit Care Med Date: 2004-07 Impact factor: 3.624
Authors: Mathijs Vogelzang; Bert G Loef; Joost G Regtien; Iwan C C van der Horst; Hein van Assen; Felix Zijlstra; Maarten W N Nijsten Journal: Intensive Care Med Date: 2008-04-04 Impact factor: 17.440
Authors: Lauren E Marsillio; Lisa A Asaro; Vijay Srinivasan; David Wypij; Lauren R Sorce; Michael S D Agus; Vinay M Nadkarni Journal: Pediatr Crit Care Med Date: 2019-12 Impact factor: 3.624
Authors: Kelly Lima Calisto; Bruno de Melo Carvalho; Eduardo Rochete Ropelle; Francine Cappa Mittestainer; Angélica Costa Aranha Camacho; Dioze Guadagnini; José Barreto Campelo Carvalheira; Mario José Abdalla Saad Journal: PLoS One Date: 2010-12-06 Impact factor: 3.240
Authors: Kelly L Calisto; Angélica C Camacho; Francine C Mittestainer; Bruno M Carvalho; Dioze Guadagnini; José B Carvalheira; Mario J Saad Journal: Crit Care Date: 2012-08-16 Impact factor: 9.097